Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)
NMTC Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
31.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
71.90%
NMTC Stock Analysis
NMTC
PE Ratio:
NMTC
PEG Ratio:
Not Available
NMTC
Forward EPS Growth (12 month):
0.00%
NMTC
PS Ratio:
3.1
NMTC
PSG Ratio:
0.1
NMTC
Forward Revenue Growth (12 month):
34.30%
NMTC Articles
No data was found